0
Observation |

Progressive Encephalomyelitis With Rigidity and Myoclonus:  The First Pediatric Case With Glycine Receptor Antibodies

Joana Damásio, MD; M. Isabel Leite, DPhil; Ester Coutinho, MD; Patrick Waters, PhD; Mark Woodhall, PhD; Manuela A. Santos, MD; Inês Carrilho, MD; Angela Vincent, FRCPath
JAMA Neurol. 2013;70(4):498-501. doi:10.1001/jamaneurol.2013.1872.
Text Size: A A A
Published online

Importance  Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case.

Observations  A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments.

Conclusions and Relevance  To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure. Clinical features, treatments, and glycine receptor alpha 1 (GlyR) antibody titers. A, Time course over 750 days of the disease. The peaks convey the relative severity of the relapses based on the number and severity of symptoms. The clinical presentation and first relapse were the most severe, with widespread rigidity, myoclonus, spinal cord and brainstem signs, and intermittent need for oxygen by mouth mask. The other 4 relapses were milder, ranging from segmental dystonia to limited stimulus-sensitive myoclonus and erratic ocular movements. The GlyR antibody levels are expressed as the highest serum (eg, 1:320 at peak) or cerebrospinal fluid (CSF) (1:2) dilution that is positive. IV indicates intravenous; IVIg, IV immunoglobulins. B, Example of patient serum IgG, diluted 1:50 and detected with Alexa Fluor 568 antihuman IgG (red, middle panel) binding to the extracellular surface of live human embryonic kidney cells expressing GlyR subunit tagged with enhanced green fluorescent protein (EGFP) (green, left panel).27 A merge of these 2 images is shown on the right.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Multimedia Related by Topic
Articles Related By Topic
Related Topics
Jobs